Are Options Traders Bullish on BIOC?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About BIOC

Biocept, Inc. is a commercial-stage molecular diagnostics company that utilizes a proprietary technology platform and a standard blood sample to provide physicians with important prognostic and predictive information to enhance individual treatment of patients with cancer. Biocept's patented technology platform captures and analyzes circulating tumor DNA, both in CTCs and in plasma (ctDNA). Biocept currently offers assays for gastric cancer, breast cancer, lung cancer, colorectal cancer and melanoma, and plans to introduce CLIA-validated assays for prostate cancer and other solid tumors in the near term.
Primary Exchange: NASDAQ
SIC Services-Commercial Physical & Biological Research
NAICS Medical Laboratories

BIOC is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.3 B 1.53181E+10 3,420 3420 0.0% 0 3 K 2858
WMCR Invesco Wilshire Micro-Cap ETF 25.9 M 2.59E+07 1,085 1085 0.0% 4E-05 960 960

Wait, Before You Leave...